Xometry, Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Cash Flows
(In thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(8,638) | $(53,110) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 16,952 | 13,741 |
| Impairment of assets | — | 49 |
| Reduction in carrying amount of right-of-use asset | 1,771 | 3,350 |
| Lease termination | — | (14) |
| Stock-based compensation | 30,961 | 25,985 |
| Income from unconsolidated joint venture | (88) | (144) |
| Donation of common stock | 4,404 | 2,080 |
| Loss on debt extinguishment | — | 16,430 |
| Amortization of deferred costs on convertible notes | 1,712 | 1,527 |
| Deferred tax benefit | (22) | (44) |
| Changes in other assets and liabilities: | ||
| Accounts receivable, net | (55,096) | (23,370) |
| Inventory | 79 | (192) |
| Prepaid expenses | 1,039 | (904) |
| Other assets | (7,468) | (1,233) |
| Accounts payable and accrued cost of revenue | 24,009 | 10,728 |
| Other accrued expenses | 9,920 | 9,100 |
| Contract liabilities | 7,395 | 3,170 |
| Lease liabilities | (1,482) | (5,202) |
| Other liabilities | (54) | (24) |
| Income taxes payable | 16 | (249) |
| Net cash provided by operating activities | 25,410 | 1,674 |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (341,705) | (6,571) |
| Proceeds from sale of marketable securities | 59,000 | 20,500 |
| Capitalization of software development and purchases of property and equipment | (38,905) | (19,911) |
| Cash paid for business combination | (4,599) | — |
| Net cash used in investing activities | (326,209) | (5,982) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of convertible notes | — | 250,000 |
| Costs incurred in connection with issuance of convertible notes | — | (8,650) |
| Payments for repurchase of convertible notes | — | (215,992) |
| Purchase of capped calls | — | (17,475) |
| Purchase of treasury stock | — | (8,080) |
| Proceeds from stock options exercised | 6,349 | 2,703 |
| Proceeds from issuance of common stock, net of underwriters’ discount | 248,400 | — |
| Payment of costs related to issuance of common stock | (776) | — |
| Proceeds from issuance of common stock under Siemens agreement | 50,000 | — |
| Net cash provided by financing activities | 303,973 | 2,506 |
| Effect of foreign currency translation on cash and cash equivalents | (38) | 415 |
| Net increase (decrease) in cash and cash equivalents | 3,136 | (1,387) |
| Cash and cash equivalents at beginning of the period | 14,996 | 22,232 |
| Cash and cash equivalents at end of the period | $18,132 | $20,845 |
| Supplemental cash flow information: | ||
| Cash paid for interest | $1,796 | $2,600 |
| Cash paid for income taxes | 1,234 | — |
| Non-cash investing and financing activities: | ||
| Stock-based compensation included in capitalized software development costs | 7,117 | — |
| Non-cash consideration in connection with business combination | 2,099 | 625 |
| Non-cash purchase of property and equipment | 108 | 74 |
| Conversion of 2027 convertible notes to common stock | 805 | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.